The clinical benefits of cyclosporine C2-level monitoring: a systematic review.

Monitoring of cyclosporine microemulsion (Neoral) using 2-hour postdose (C2) levels is alleged to improve clinical outcomes, but the efficacy of this strategy is uncertain.